4.20
price down icon5.83%   -0.26
pre-market  Vorhandelsmarkt:  4.03   -0.17   -4.05%
loading

Annovis Bio Inc Aktie (ANVS) Neueste Nachrichten

pulisher
Dec 10, 2025

Keeping Neurodegeneration Top Of Mind: Is Annovis Bio's Pipeline Progress Enough? - RTTNews

Dec 10, 2025
pulisher
Dec 08, 2025

Annovis Bio director Hoffman buys $193,794 in shares By Investing.com - Investing.com Canada

Dec 08, 2025
pulisher
Dec 08, 2025

Annovis Bio (NYSE:ANVS) Director Purchases $193,950.00 in Stock - MarketBeat

Dec 08, 2025
pulisher
Dec 08, 2025

Annovis Bio director Hoffman buys $193,794 in shares - Investing.com

Dec 08, 2025
pulisher
Dec 07, 2025

Published on: 2025-12-08 04:36:17 - BỘ NỘI VỤ

Dec 07, 2025
pulisher
Dec 05, 2025

Annovis Bio Inc. (ANVS) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade

Dec 05, 2025
pulisher
Dec 05, 2025

Can Annovis Bio Inc. stock deliver consistent EPS growth2025 Retail Activity & High Yield Stock Recommendations - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Is Annovis Bio Inc. stock a top hedge fund pickEarnings Beat & High Conviction Buy Zone Picks - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Why institutional investors increase stakes in Annovis Bio Inc. stockEarnings Performance Report & Capital Efficiency Focused Ideas - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Why Annovis Bio Inc. stock fits value portfoliosJuly 2025 Summary & Low Risk High Reward Ideas - Newser

Dec 05, 2025
pulisher
Dec 05, 2025

Why Annovis Bio Inc. stock is a must watch tickerEarnings Risk Report & Weekly Watchlist for Consistent Profits - Newser

Dec 05, 2025
pulisher
Dec 04, 2025

Annovis Bio (ANVS) Short Interest & Short Float | Updated Dec 2025 - MarketBeat

Dec 04, 2025
pulisher
Dec 04, 2025

How Annovis Bio Inc. stock compares with top peers2025 Price Targets & Weekly Stock Breakout Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

How geopolitical risks impact Annovis Bio Inc. stockWeekly Trade Recap & Weekly Return Optimization Alerts - Newser

Dec 04, 2025
pulisher
Dec 04, 2025

Annovis Bio (ANVS) Stock Analysis Report | Financials & Insights - Benzinga

Dec 04, 2025
pulisher
Dec 03, 2025

Annovis Bio to Present Comprehensive Buntanetap Data at Parkinson Study Group Meeting - citybuzz

Dec 03, 2025
pulisher
Dec 03, 2025

Annovis Bio, Inc. to Present At the 2025 Annual Meeting of the Parkinson Study Group - marketscreener.com

Dec 03, 2025
pulisher
Dec 03, 2025

Annovis To Present at the 2025 Annual Meeting of the Parkinson Study Group - The Manila Times

Dec 03, 2025
pulisher
Dec 03, 2025

Annovis Bio (NYSE: ANVS) to share buntanetap cognitive data in PD, AD at 2025 PSG meeting - Stock Titan

Dec 03, 2025
pulisher
Dec 02, 2025

Annovis Rallies Around Phase 3 Alzheimer’s Push as New Data Signals Disease-Modifying Promise - MSN

Dec 02, 2025
pulisher
Dec 02, 2025

Annovis Bio, Inc. (NYSE:ANVS) Receives Consensus Rating of "Hold" from Brokerages - MarketBeat

Dec 02, 2025
pulisher
Nov 29, 2025

Certain Stock Options of Annovis Bio, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - marketscreener.com

Nov 29, 2025
pulisher
Nov 29, 2025

Certain Warrants of Annovis Bio, Inc. are subject to a Lock-Up Agreement Ending on 30-NOV-2025. - MarketScreener

Nov 29, 2025
pulisher
Nov 29, 2025

Why analysts remain bullish on Annovis Bio Inc. stock2025 Earnings Impact & Daily Profit Focused Stock Screening - BỘ NỘI VỤ

Nov 29, 2025
pulisher
Nov 26, 2025

Michael Hoffman Acquires 39,200 Shares of Annovis Bio (NYSE:ANVS) Stock - MarketBeat

Nov 26, 2025
pulisher
Nov 25, 2025

Annovis Bio : Amendment to Statement of Changes in Beneficial Ownership (Form 4/A) - marketscreener.com

Nov 25, 2025
pulisher
Nov 25, 2025

Annovis Bio director Hoffman buys $159k in shares By Investing.com - Investing.com Nigeria

Nov 25, 2025
pulisher
Nov 25, 2025

Alzheimer's Disease Market to Evolve Rapidly Over the Next - openPR.com

Nov 25, 2025
pulisher
Nov 25, 2025

Annovis Bio director Hoffman buys $159k in shares - Investing.com

Nov 25, 2025
pulisher
Nov 25, 2025

Annovis Bio Director Michael B Hoffman Buys 39,200 Shares - TradingView

Nov 25, 2025
pulisher
Nov 25, 2025

Parkinson’s Breakthrough? New Data Shows Drug May Reverse Cognitive Decline - MyChesCo

Nov 25, 2025
pulisher
Nov 24, 2025

Annovis Announces Two Presentations at the CTAD 2025 Conference - The Manila Times

Nov 24, 2025
pulisher
Nov 22, 2025

Annovis Bio director Hoffman buys $69.9k in ANVS stock By Investing.com - Investing.com Nigeria

Nov 22, 2025
pulisher
Nov 21, 2025

Annovis Bio director Hoffman buys $69.9k in ANVS stock - Investing.com

Nov 21, 2025
pulisher
Nov 21, 2025

Chmn Hoffman Buys 20,000 ($69.9K) Of Annovis Bio Inc [ANVS] - TradingView

Nov 21, 2025
pulisher
Nov 21, 2025

Will Annovis Bio Inc. stock attract long term capital inflows2025 Short Interest & Intraday High Probability Setup Alerts - newser.com

Nov 21, 2025
pulisher
Nov 21, 2025

How Annovis Bio Inc. stock reacts to stronger dollarJuly 2025 Technicals & Long-Term Safe Investment Ideas - newser.com

Nov 21, 2025
pulisher
Nov 20, 2025

Annovis Bio Inc Stock Analysis and ForecastDividend Stability Analysis & Small Budget Capital Growth - earlytimes.in

Nov 20, 2025
pulisher
Nov 20, 2025

How Annovis Bio Inc. stock reacts to monetary easingTake Profit & Verified Momentum Watchlists - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Can Annovis Bio Inc. stock deliver sustainable ROEWeekly Stock Report & Daily Volume Surge Trade Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Annovis Bio Inc. stock benefit from automationJuly 2025 Closing Moves & AI Forecasted Stock Moves - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Annovis Bio Inc. stock outperform Dow JonesShare Buyback & Detailed Earnings Play Alerts - newser.com

Nov 20, 2025
$38.26
price up icon 0.45%
$95.17
price up icon 0.01%
$31.24
price up icon 1.00%
$95.73
price down icon 0.12%
biotechnology ONC
$322.68
price up icon 1.25%
$189.85
price down icon 2.22%
Kapitalisierung:     |  Volumen (24h):